Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
27 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Fibrocell Science, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Fibrocell Science, Inc. - Product Pipeline Review - 2014', provides an overview of the Fibrocell Science, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Fibrocell Science, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Fibrocell Science, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Fibrocell Science, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Fibrocell Science, Inc.'s pipeline products Reasons to buy - Evaluate Fibrocell Science, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Fibrocell Science, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Fibrocell Science, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Fibrocell Science, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Fibrocell Science, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Fibrocell Science, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Fibrocell Science, Inc. Snapshot 4 Fibrocell Science, Inc. Overview 4 Key Information 4 Key Facts 4 Fibrocell Science, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Fibrocell Science, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Fibrocell Science, Inc. - Pipeline Products Glance 10 Fibrocell Science, Inc. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Fibrocell Science, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Discovery Products/Combination Treatment Modalities 12 Fibrocell Science, Inc. - Drug Profiles 13 azficel-T 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Gene Modified Autologous Fibroblast Cell Therapy 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Autologous Fibroblast Cell Therapy for EDS-HT 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Fibrocell Science, Inc. - Pipeline Analysis 16 Fibrocell Science, Inc. - Pipeline Products by Route of Administration 16 Fibrocell Science, Inc. - Pipeline Products by Molecule Type 17 Fibrocell Science, Inc. - Recent Pipeline Updates 18 Fibrocell Science, Inc. - Dormant Projects 21 Fibrocell Science, Inc. - Company Statement 22 Fibrocell Science, Inc. - Locations And Subsidiaries 25 Head Office 25 Other Locations & Subsidiaries 25 Appendix 26 Methodology 26 Coverage 26 Secondary Research 26 Primary Research 26 Expert Panel Validation 26 Contact Us 27 Disclaimer 27
List of Tables Fibrocell Science, Inc., Key Information 4 Fibrocell Science, Inc., Key Facts 4 Fibrocell Science, Inc. - Pipeline by Indication, 2014 7 Fibrocell Science, Inc. - Pipeline by Stage of Development, 2014 8 Fibrocell Science, Inc. - Monotherapy Products in Pipeline, 2014 9 Fibrocell Science, Inc. - Phase II, 2014 10 Fibrocell Science, Inc. - Preclinical, 2014 11 Fibrocell Science, Inc. - Discovery, 2014 12 Fibrocell Science, Inc. - Pipeline by Route of Administration, 2014 16 Fibrocell Science, Inc. - Pipeline by Molecule Type, 2014 17 Fibrocell Science, Inc. - Recent Pipeline Updates, 2014 18 Fibrocell Science, Inc. - Dormant Developmental Projects,2014 21 Fibrocell Science, Inc., Subsidiaries 25
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.